Broqua, Pierre
Cliniques Universitaires Saint-Luc · Université Libre de Bruxelles · University of Antwerp · Virginia Commonwealth University · University of California San Diego · Sorbonne Université · Antwerp University Hospital · Inventiva (France) · Newcastle University · UCLouvain
2 papers on CoChat
Most cited papers
- Verified
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., et al. (2021) · New England Journal of Medicine
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 801
- Verified
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Boyer-Diaz, Z., Aristu-Zabalza, P., Andrés-Rozas, M., Robert, C., Ortega-Ribera, M., Fernández-Iglesias, A., Broqua, P., Junien, J.-L., Wettstein, G., Bosch, J., et al. (2021) · Journal of Hepatology
Liver Disease and TransplantationLiver physiology and pathology
Cited by 168
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free